I'd like some euros therapeutic classification of amoxil CSL Ltd shed 2.9 percent to A$65.83, erasing mostits rally in the previous session, but was still trading nearall-time highs. The world's No.2 blood products maker reported a19 percent rise in full-year net profit to $1.22 billion, afterstrong sales of its core products offset a strong Australiandollar.